Arcutis公布Zoryve®(罗氟司特)乳膏0.05%用于婴幼儿轻中度特应性皮炎的Integument-Infant二期试验积极顶线结果

美股速递
Feb 02

Arcutis Biotherapeutics Inc. (ARQT) 宣布,其针对婴幼儿轻中度特应性皮炎(AD)的Zoryve®(罗氟司特)乳膏0.05%所进行的Integument-Infant二期临床试验,已获得积极的顶线结果。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10